Image from Pexels
From simple aids for senses such as eyeglasses, ear trumpets and Leonardo da Vinci’s sketches of a mechanical pedometer, wearable medical technology moved to battery-operated devices for monitoring and treatment to the current generation that is electronic.
Worn on or attached to the body, these products continuously or regularly collect, analyze and send health data. They are used to monitor, diagnose, treat or manage medical conditions, and as such are built and proven for accuracy and reliability that's good enough to support medical decisions. These clinical-grade devices are not to be confused with consumer-grade ones that are designed to be convenient, engaging and good at tracking trends.
What counts as a wearable medical device
A wearable is a medical device when it is intended to diagnose, treat, monitor, mitigate or prevent a disease or condition. The category includes diagnostic and monitoring, therapeutic, and assistive and rehabilitation devices. Under the first are ECG patches, Holter monitors, heart-failure sensors, continuous glucose monitors, vital-sign patches used in hospitals and remote monitoring, medical-grade pulse oximeters, ambulatory blood pressure monitors, seizure detection devices, Parkinson's and tremor monitors, home sleep apnea testing devices and fetal and pregnancy monitors.
For therapy, there are insulin pumps and on-body drug injectors, wearable defibrillators, nerve and muscle stimulators for pain (TENS) and migraine as well as prescription digital therapeutics paired with wearables.
Hearing aids, including over-the-counter ones, medical exoskeletons and motorized braces and fall detection systems for clinical or elder care are in the assistive and rehabilitation subcategory.
Where consumer fitness trackers and smartwatches fall
Fitness trackers and some smartwatches with basic functions, including step counting, sleep tracking, heart rate during exercise, stress or recovery scores, are general wellness products.
The Food and Drug Administration (FDA) defines these devices based on the intended use, which is maintaining or encouraging general health or healthy activity to reduce the risk or impact of chronic diseases. They are also not invasive, not implanted, and do not involve technology that would be unsafe without regulatory controls and therefore are low risk.
In January 2026, FDA reissued its General Wellness guidance on wellness products, making it clear that these are not intended to diagnose, prevent or treat a disease and are not a substitute for an FDA-authorized device. Such products may show values, ranges, trends and baselines in a sleep, activity, stress or recovery context and may also tell users that seeing a healthcare professional might help. But that notice can't name a disease, call a reading abnormal, use clinical thresholds or provide ongoing disease-management alerts.
Market opportunities
Estimates on the market size of wearable medical devices and projected expansion vary but all point to strong growth.
Consumer devices still bring in most of the revenue, but clinical-grade wearables are catching up quickly. Products with FDA clearance, clinical evidence and insurance coverage can charge more and are harder for competitors to copy.
In terms of revenue, devices that monitor heart rhythm, glucose or blood pressure account for the majority share, while those that deliver treatment are expected to grow fastest. Examples of the latter product type include patch insulin pumps, nerve-stimulation devices for pain, migraine or sleep, and drug-delivery patches.
Hospital and remote monitoring are another. In general wards, nurses usually check vital signs only every few hours, and problems can be missed in between. There are already hospitals using on-body biosensors to address this as well as in post-discharge care to prevent readmissions. In the US, Medicare pays for remote patient monitoring, which includes digital medical devices that collect a patient's health data at home and send it to doctors electronically.
For chronic disease management, there are continuous glucose monitors that are available over the counter to people with prediabetes, type 2 diabetes and weight-management needs. Likewise, devices to track and monitor heart failure, COPD, AFib and sleep apnea exist. Cuffless blood pressure monitoring is technically hard to solve, but there is a large unmet need for it.
Devices that continuously measure hydration, lactate, stress hormone, ketones, alcohol, hormones for fertility and menopause, and drug levels are a marketing opportunity as well. Sweat, skin-fluid and breath sensors, meanwhile, are early-stage research areas.
There are also new device formats that can be more comfortable, so people may keep wearing them longer. They include smart rings, skin patches, smart clothing, earbuds and smart contact lenses.
Software and AI are another realm, which can connect devices to electronic health records and make products work together. Algorithms can turn raw sensor data into useful clinical alerts, such as early warning of sepsis or heart failure getting worse while software can filter data so clinicians are not overwhelmed with alerts.
By extension, wearable medical technology creates the need for longer-lasting or self-powered batteries, flexible electronics, skin-friendly adhesives, low-power chips, cybersecurity, data privacy and compliance tools as well as regulatory consulting for companies bringing devices to market.The specific markets are there and can be found in aging populations, clinical trials, women’s health, mental health therapy, workplace safety, and athletic and military training.
